Fundraising Fox

Mesentech Inc.

Vancouver · British Columbia, Canada corporation · 2 known investors

mesentech.com ↗

Mesentech develops prostaglandin prodrugs aimed at musculoskeletal regeneration. The company operates in the biotechnology and drug development space.

BiotechHealthtech

Founders & leadership

BY
Barbara YanniDirector
SW
Samuel WuDirector
DH
David HymanExecutive Officer
RN
Robert Norman YoungExecutive Officer, Director
JM
Jay MohrDirector
DD
David DvorakDirector
JP
Jonathan PolakExecutive Officer, Director, Promoter

Investors · 2

Beresford VenturesOrlando
WUTIF CapitalVancouver · $50K – $300Kvia Mike Volker · inferred

Reported raises · per SEC filings

Form D private placements
▶$3.9MraisedApr 2022 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Barbara YanniDirector
  • Samuel WuDirector
  • David HymanExecutive Officer
  • Robert Norman YoungExecutive Officer, Director
  • Jay MohrDirector
  • David DvorakDirector
  • Jonathan PolakExecutive Officer, Director, Promoter
Offering amount
$7M
Amount sold
$3.9M
First sale
Mar 2022
Incorporated
Corporation, British Columbia, Canada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.